Researchers in protective suits work in a lab at the Yisheng Biopharma company, where researchers are trying to develop a vaccine for the COVID-19 coronavirus, in Shenyang, in China’s northeast Liaoning province, on June 9, 2020. - China has mobilised its army and fast-tracked tests in the global race to find a coronavirus vaccine, and is involved in several of the dozen or so international clinical trials currently under way. (Photo by NOEL CELIS / AFP)
Život
Kinezi tvrde da će njihova cjepiva protiv korone biti spremna za javnost već u studenom ove godine
Kina ima četiri cjepiva protiv covida-19 u završnoj fazi kliničkog ispitivanja
Piše Hina 15. 09. 2020.
Laboratory coronavirus vaccine antiviral biology research antivirus doctors vector illustration. Scientists in laboratory, chemical researchers with lab equipment. (Laboratory coronavirus vaccine antiviral biology research antivirus doctors vector ill
Život
Znanstvenici ubrzano traže terapiju protiv korone. Isprobaju lijekove protiv, primjerice, ebole, malarije i SARS-a
Najviše obećavaju istraživanja koja se provode u Kini i SAD-u
Piše Eva Benedik 3 preporuka 29. 03. 2020.
(FILES) In this file handout illustration image obtained February 27, 2020 courtesy of the National Institutes of Health taken with a scanning electron microscope shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the US, emerging from the surface of cells (blue/pink) cultured in the lab. - The US biotech firm Inovio reported preliminary but encouraging results June 30, 2020 from tests of an experimental coronavirus vaccine. Administered to 40 volunteers, it triggered an immune system response in 94 percent of those who completed the so-called phase one clinical trial, meaning they received two injections, four weeks apart.Inovio's vaccine, called INO-4800, is designed to inject DNA into a person so as to set off a specific immune system response against the SARS-CoV-2 virus. (Photo by Handout / National Institutes of Health / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /NATIONAL INSTITUTES OF HEALTH/NIAID-RML/HANDOUT " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
Život
Trenutno se na ljudima testira 17 mogućih cjepiva protiv koronavirusa, objavio je WHO
Izvijestili su i da je cjepivo s Oxfora ušlo u treću fazu kliničkog ispitivanja
Piše Hina 57 preporuka 03. 07. 2020.
Život

Kina je odobrila testiranje cjepiva protiv korone na ljudima

Cjepivo je kultivirano u stanicama insekata

Workers package rabies vaccine at a lab at the Yisheng Biopharma company, where researchers are trying to develop a vaccine for the COVID-19 coronavirus, in Shenyang, in China's northeast Liaoning province, on June 9, 2020. - China has mobilised its army and fast-tracked tests in the global race to find a coronavirus vaccine, and is involved in several of the dozen or so international clinical trials currently under way. (Photo by NOEL CELIS / AFP)
FOTO: AFP
22. 08. 2020. 48 preporuka

Kina je odobrila testiranje na ljudima potencijalnog cjepiva protiv koronavirusa koje je kultivirano u stanicama insekata, objavila je lokalna vlast u jugozapadnom gradu Chengduu u subotu.

Kina se nalazi usred globalne utrke razvoja isplativog cjepiva, u svrhu zaustavljanja pandemije koronavirusa.

Korištenje stanica insekata za razvoj proteina za cjepivo protiv koronavirusa – prvo u Kini – moglo bi ubrzati proizvodnju na veliko, rekla je gradska vlast u Chengduu u najavi na društvenoj mreži WeChat.

Faza kliničkog ispitivanja

Cjepivo koje je proizvela bolnica Zapadna Kina pri sveučilištu Sichuan u Chengedu, odobrila je Nacionalna uprava za medicinske proizvode, kako bi ušlo u fazu kliničkog ispitivanja, pisalo je u najavi.

Testiranje na majmunima pokazalo je da cjepivo prevenira SARS-CoV-2 zaraze bez vidljivih nuspojava. Kineski znanstvenici već vode istraživanja barem još osam potencijalnih cjepiva protiv koronavirusa koja se nalaze u različitim stadijima kliničkih ispitivanja.

Strane kompanije, poput njemačke BioNTech i američke Inovio Pharma, također surađuju s lokalnim tvrtkama kako bi testirale svoja eksperimentalna cjepiva u Kini.

Koronavirus, Kina, cjepivo,